During the past decade, Hanil General Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hanil General Hospital" #1 collaborator was "Daiichi Sankyo Korea Co., Ltd." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hanil General Hospital" are "Diphtheria" (2 trials), "Tetanus" (2 trials), "Dyslipidemia Associated With Type II Diabetes Mellitus" (1 trials), "Haemophilus Influenzae Type B Infection" (1 trials) and "Hepatitis A Vaccine" (1 trials). Many other conditions were trialed in "Hanil General Hospital" in a lesser frequency.

Most popular intervention types in "Hanil General Hospital" are "Biological" (4 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "BR-TD-1001" (1 trials), "DTaP-IPV combination vaccine" (1 trials), "Haemophilus influenza type b conjugate vaccine" (1 trials), "Havrix Inj" (1 trials) and "Inactivated hepatitis A vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hanil General Hospital" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Hanil General Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hanil General Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hanil General Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".